Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 214

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 214
---
 | ​ | ​ | ​ | ​                          | ​ |    700,000 | ​ | ​ | ​ | ​                                | ​ |    700,000 | ​ | ​ | ​ | ​                          | ​ |    700,000 | ​ | ​ |
| Equity PIPE Investor                                                         | ​ | ​ | ​                                    | ​ |  1,500,000 | ​ | ​ | ​ | ​                          | ​ |  1,500,000 | ​ | ​ | ​ | ​                                | ​ |  1,500,000 | ​ | ​ | ​ | ​                          | ​ |  1,500,000 | ​ | ​ |
| Liminatus Members                                                            | ​ | ​ | ​                                    | ​ | 17,500,000 | ​ | ​ | ​ | ​                          | ​ | 17,500,000 | ​ | ​ | ​ | ​                                | ​ | 17,500,000 | ​ | ​ | ​ | ​                          | ​ | 17,500,000 | ​ | ​ |
| Pro forma weighted average Class A shares calculation, basic and diluted﻿(1) | ​ | ​ | ​                                    | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ | ​ | ​                                | ​ | 26,774,477 | ​ | ​ | ​ | ​                          | ​ | 26,600,000 | ​ | ​ |

(1) Number of shares determined based on a price of $10.00 per share. Such price is subject to adjustment based on the five day volume-weighted average price prior to the filing of a resale registration statement covering such shares.

97

TABLE OF CONTENTS

### SPECIAL MEETING OF IRIS STOCKHOLDERS

#### General
We are furnishing this proxy statement/prospectus to our stockholders as part of the solicitation of proxies by the Iris Board for use at the Special Meeting to be held on March 4, 2025, and at any adjournment or postponement thereof. This proxy statement/prospectus is first being furnished to our stockholders on or about February 7, 2025.

#### Date and Time of Special Meeting
The Special Meeting will be held at 10:00 a.m., Eastern Time, on March 4, 2025, or such other date and time to which such meeting may be adjourned